TipRanks
RemeGen Co. Ltd. Class H (REGMF)
OTHER OTC:REGMF

Compare RemeGen Co. Ltd. Class H (REGMF) vs. Competitors

2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
RemeGen Co. Ltd. Class H
$10.22
$7.56B
10.38
-42.83%
9 Buy
2 Hold
0 Sell
Strong Buy
Akeso, Inc.
HK$94.20
HK$100.50B
-89.30
-17.03%
13 Buy
1 Hold
0 Sell
Strong Buy
Alphamab Oncology
HK$11.90
HK$7.17B
-36.42
-47.31%
―
InnoCare Pharma Ltd.
HK$11.75
HK$19.03B
20.87
-23.41%
4 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$27.54
HK$34.93B
-78.89
-40.57%
2 Buy
1 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$66.75
HK$27.67B
27.17
-33.00%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
REGMF
RemeGen Co. Ltd. Class H
9.05
-6.78
-42.83%
HK:9926
Akeso, Inc.
109.10
-17.50
-13.82%
HK:9966
Alphamab Oncology
7.36
-6.48
-46.82%
HK:9969
InnoCare Pharma Ltd.
12.73
-2.07
-13.99%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
17.65
-9.37
-34.68%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
50.75
-18.25
-26.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts